{"protocolSection": {"identificationModule": {"nctId": "NCT01951638", "orgStudyIdInfo": {"id": "15829"}, "secondaryIdInfos": [{"id": "2013-002288-25", "type": "EUDRACT_NUMBER"}], "organization": {"fullName": "Bayer", "class": "INDUSTRY"}, "briefTitle": "Phase IIb Safety and Efficacy Study of Four Dose Regimens of BAY1021189 in Patients With Heart Failure and Preserved Ejection Fraction Suffering From Worsening Chronic Heart Failure (SOCRATES-PRESERVED)", "officialTitle": "A Randomized Parallel-group, Placebo-controlled, Double-blind, Multi-center Dose Finding Phase II Trial Exploring the Pharmacodynamic Effects, Safety and Tolerability, and Pharmacokinetics of Four Dose Regimens of the Oral sGC Stimulator BAY1021189 Over 12 Weeks in Patients With Worsening Heart Failure and Preserved Ejection Fraction (HFpEF)"}, "statusModule": {"statusVerifiedDate": "2021-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2013-11-06", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2015-08-18", "type": "ACTUAL"}, "completionDateStruct": {"date": "2015-09-16", "type": "ACTUAL"}, "studyFirstSubmitDate": "2013-09-24", "studyFirstSubmitQcDate": "2013-09-24", "studyFirstPostDateStruct": {"date": "2013-09-26", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2021-01-20", "resultsFirstSubmitQcDate": "2021-01-21", "resultsFirstPostDateStruct": {"date": "2021-02-12", "type": "ACTUAL"}, "dispFirstSubmitDate": "2015-09-23", "dispFirstSubmitQcDate": "2015-10-09", "dispFirstPostDateStruct": {"date": "2015-11-03", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2021-02-25", "lastUpdatePostDateStruct": {"date": "2021-03-16", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Bayer", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": true}, "descriptionModule": {"briefSummary": "Objective of the study is to find the optimal dose of the once daily oral soluble guanylate cyclase stimulator (sGC) BAY1021189 for Phase III that can be given in addition to standard diuretic and comorbidity treatment for heart failure with preserved ejection fraction (HFpEF)"}, "conditionsModule": {"conditions": ["Heart Failure"], "keywords": ["Worsening Heart Failure", "Heart Failure with Preserved Ejection Fraction"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE2"], "designInfo": {"allocation": "RANDOMIZED", "interventionModel": "PARALLEL", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "QUADRUPLE", "whoMasked": ["PARTICIPANT", "CARE_PROVIDER", "INVESTIGATOR", "OUTCOMES_ASSESSOR"]}}, "enrollmentInfo": {"count": 477, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Vericiguat (BAY1021189)(10 mg)", "type": "EXPERIMENTAL", "description": "2.5 mg orally once daily for 2 weeks, up-titration to 5 mg orally once daily for 2 weeks, up-titration to 10 mg orally once daily for 8 weeks", "interventionNames": ["Drug: Vericiguat (BAY1021189) (1.25 mg)", "Drug: Vericiguat (BAY1021189) (5 mg)"]}, {"label": "Vericiguat (BAY1021189) (5 mg)", "type": "EXPERIMENTAL", "description": "2.5 mg orally once daily for 2 weeks, then 5 mg orally once daily for 10 weeks (with sham titration)", "interventionNames": ["Drug: Vericiguat (BAY1021189) (1.25 mg)", "Drug: Vericiguat (BAY1021189) (5 mg)"]}, {"label": "Vericiguat (BAY1021189) (2.5 mg)", "type": "EXPERIMENTAL", "description": "2.5 mg orally once daily for 12 weeks (with sham titrations)", "interventionNames": ["Drug: Vericiguat (BAY1021189) (1.25 mg)"]}, {"label": "Vericiguat (BAY1021189) (1.25 mg)", "type": "EXPERIMENTAL", "description": "1.25 mg orally once daily for 12 weeks (with sham titrations)", "interventionNames": ["Drug: Vericiguat (BAY1021189) (1.25 mg)"]}, {"label": "Placebo", "type": "PLACEBO_COMPARATOR", "description": "Orally once daily for 12 weeks (with sham titrations)", "interventionNames": ["Drug: Placebo"]}], "interventions": [{"type": "DRUG", "name": "Vericiguat (BAY1021189) (1.25 mg)", "description": "1.25 mg BAY1021189 tablets", "armGroupLabels": ["Vericiguat (BAY1021189) (1.25 mg)", "Vericiguat (BAY1021189) (2.5 mg)", "Vericiguat (BAY1021189) (5 mg)", "Vericiguat (BAY1021189)(10 mg)"]}, {"type": "DRUG", "name": "Vericiguat (BAY1021189) (5 mg)", "description": "5 mg BAY1021189 tablets", "armGroupLabels": ["Vericiguat (BAY1021189) (5 mg)", "Vericiguat (BAY1021189)(10 mg)"]}, {"type": "DRUG", "name": "Placebo", "armGroupLabels": ["Placebo"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Change From Baseline to Week 12 in Log-transformed N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)", "description": "NTproBNP is a circulating plasma biomarker of cardiovascular function and prognosis in heart failure (HF).", "timeFrame": "Baseline, Week 12 (end of treatment [EOT])"}, {"measure": "Change From Baseline to Week 12 in Left Atrial Volume (LAV)", "description": "Left atrial volume was measured by echocardiography.", "timeFrame": "Baseline, Week 12 (EOT)"}], "otherOutcomes": [{"measure": "Change From Baseline to Week 12 Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)", "description": "Blood pressure was measured after at least 10 minutes resting in a sitting position (3 measurements taken approximately 2 minutes apart).The changes in blood pressure were recorded and the mean of the three measurements was analyzed.", "timeFrame": "Baseline, Week 12 (EOT)"}, {"measure": "Change From Baseline to Week 12 in Heart Rate", "description": "Heart rate was measured after 10 minutes resting in a sitting position (3 measurements taken approximatly 2 minutes apart). The changes in heart rate were recorded and the mean of the three measurements was analyzed.", "timeFrame": "Baseline, Week 12 (EOT)"}, {"measure": "Number of Subjects With Clinical Events (Heart Failure Hospitalization and Cardio-vascular [CV] Mortality)", "description": "Clinical events (heart failure and mortality) were analyzed as CV death, and HF hospitalization at specified time points.", "timeFrame": "Baseline up to Week 16 including 12 week treatment period and 4 week follow-up period"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Worsening chronic heart failure (WCHF) requiring hospitalization (or intravenous diuretic treatment for HF without hospitalization) with initiation of study treatment after clinical stabilization\n* Left ventricular ejection fraction (LVEF) \\>/= 45% by echocardiography at randomization\n\nExclusion Criteria:\n\n* Intravenous inotropes at any time after hospitalization", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Bayer Study Director", "affiliation": "Bayer", "role": "STUDY_DIRECTOR"}], "locations": [{"city": "Fountain Valley", "state": "California", "zip": "92708", "country": "United States", "geoPoint": {"lat": 33.70918, "lon": -117.95367}}, {"city": "Fort Lauderdale", "state": "Florida", "zip": "33308", "country": "United States", "geoPoint": {"lat": 26.12231, "lon": -80.14338}}, {"city": "Naples", "state": "Florida", "zip": "34102", "country": "United States", "geoPoint": {"lat": 26.14234, "lon": -81.79596}}, {"city": "Macon", "state": "Georgia", "zip": "31201", "country": "United States", "geoPoint": {"lat": 32.84069, "lon": -83.6324}}, {"city": "Chicago", "state": "Illinois", "zip": "60611-2908", "country": "United States", "geoPoint": {"lat": 41.85003, "lon": -87.65005}}, {"city": "Iowa City", "state": "Iowa", "zip": "52242", "country": "United States", "geoPoint": {"lat": 41.66113, "lon": -91.53017}}, {"city": "New Orleans", "state": "Louisiana", "zip": "70112-1396", "country": "United States", "geoPoint": {"lat": 29.95465, "lon": -90.07507}}, {"city": "Detroit", "state": "Michigan", "zip": "48202", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"city": "Minneapolis", "state": "Minnesota", "zip": "55422", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"city": "Jackson", "state": "Mississippi", "zip": "39216-4505", "country": "United States", "geoPoint": {"lat": 32.29876, "lon": -90.18481}}, {"city": "Newark", "state": "New Jersey", "zip": "07103", "country": "United States", "geoPoint": {"lat": 40.73566, "lon": -74.17237}}, {"city": "Buffalo", "state": "New York", "zip": "14215", "country": "United States", "geoPoint": {"lat": 42.88645, "lon": -78.87837}}, {"city": "Pittsburgh", "state": "Pennsylvania", "zip": "15212", "country": "United States", "geoPoint": {"lat": 40.44062, "lon": -79.99589}}, {"city": "Charleston", "state": "South Carolina", "zip": "29425", "country": "United States", "geoPoint": {"lat": 32.77657, "lon": -79.93092}}, {"city": "Germantown", "state": "Tennessee", "zip": "38138", "country": "United States", "geoPoint": {"lat": 35.08676, "lon": -89.81009}}, {"city": "Nashville", "state": "Tennessee", "zip": "37232-8802", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"city": "Milwaukee", "state": "Wisconsin", "zip": "53215", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}, {"city": "Darlinghurst", "state": "New South Wales", "zip": "2010", "country": "Australia", "geoPoint": {"lat": -33.87939, "lon": 151.21925}}, {"city": "Brisbane", "state": "Queensland", "zip": "4029", "country": "Australia", "geoPoint": {"lat": -27.46794, "lon": 153.02809}}, {"city": "Brisbane", "state": "Queensland", "zip": "4064", "country": "Australia", "geoPoint": {"lat": -27.46794, "lon": 153.02809}}, {"city": "Redcliffe", "state": "Queensland", "zip": "4020", "country": "Australia", "geoPoint": {"lat": -31.93845, "lon": 115.94645}}, {"city": "Hobart", "state": "Tasmania", "zip": "7000", "country": "Australia", "geoPoint": {"lat": -42.87936, "lon": 147.32941}}, {"city": "St. P\u00f6lten", "state": "Nieder\u00f6sterreich", "zip": "3100", "country": "Austria", "geoPoint": {"lat": 48.2, "lon": 15.63333}}, {"city": "Linz", "state": "Ober\u00f6sterreich", "zip": "4010", "country": "Austria", "geoPoint": {"lat": 48.30639, "lon": 14.28611}}, {"city": "Linz", "state": "Ober\u00f6sterreich", "zip": "4020", "country": "Austria", "geoPoint": {"lat": 48.30639, "lon": 14.28611}}, {"city": "Graz", "state": "Steiermark", "zip": "8036", "country": "Austria", "geoPoint": {"lat": 47.06667, "lon": 15.45}}, {"city": "Salzburg", "zip": "5020", "country": "Austria", "geoPoint": {"lat": 47.79941, "lon": 13.04399}}, {"city": "Wien", "zip": "1090", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"city": "Wien", "zip": "1220", "country": "Austria", "geoPoint": {"lat": 48.20849, "lon": 16.37208}}, {"city": "Brugge", "zip": "8000", "country": "Belgium", "geoPoint": {"lat": 51.20892, "lon": 3.22424}}, {"city": "Bruxelles - Brussel", "zip": "1200", "country": "Belgium", "geoPoint": {"lat": 50.85045, "lon": 4.34878}}, {"city": "Gent", "zip": "9000", "country": "Belgium", "geoPoint": {"lat": 51.05, "lon": 3.71667}}, {"city": "Gilly", "zip": "6060", "country": "Belgium", "geoPoint": {"lat": 50.42449, "lon": 4.4789}}, {"city": "HUY", "zip": "4500", "country": "Belgium", "geoPoint": {"lat": 50.51894, "lon": 5.23284}}, {"city": "Mechelen", "zip": "2800", "country": "Belgium", "geoPoint": {"lat": 51.02574, "lon": 4.47762}}, {"city": "MOL", "zip": "2400", "country": "Belgium", "geoPoint": {"lat": 51.19188, "lon": 5.11662}}, {"city": "Roeselare", "zip": "8800", "country": "Belgium", "geoPoint": {"lat": 50.94653, "lon": 3.12269}}, {"city": "Burgas", "zip": "8018", "country": "Bulgaria", "geoPoint": {"lat": 42.50606, "lon": 27.46781}}, {"city": "Sofia", "zip": "1202", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Sofia", "zip": "1233", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Sofia", "zip": "1309", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Sofia", "zip": "1527", "country": "Bulgaria", "geoPoint": {"lat": 42.69751, "lon": 23.32415}}, {"city": "Stara Zagora", "zip": "6000", "country": "Bulgaria", "geoPoint": {"lat": 42.43278, "lon": 25.64194}}, {"city": "Toronto", "state": "Ontario", "zip": "M5B 1W8", "country": "Canada", "geoPoint": {"lat": 43.70011, "lon": -79.4163}}, {"city": "Montreal", "state": "Quebec", "zip": "H1T 1C8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"city": "Montreal", "state": "Quebec", "zip": "H2W 1T8", "country": "Canada", "geoPoint": {"lat": 45.50884, "lon": -73.58781}}, {"city": "Saint-Jean-sur-Richelieu", "state": "Quebec", "zip": "J3A 1C3", "country": "Canada", "geoPoint": {"lat": 45.30713, "lon": -73.26259}}, {"city": "Sherbrooke", "state": "Quebec", "zip": "J1G 2E8", "country": "Canada", "geoPoint": {"lat": 45.40008, "lon": -71.89908}}, {"city": "Quebec", "zip": "G1V 4G5", "country": "Canada", "geoPoint": {"lat": 46.81228, "lon": -71.21454}}, {"city": "Kromeriz", "zip": "767 01", "country": "Czechia", "geoPoint": {"lat": 49.29785, "lon": 17.39312}}, {"city": "Praha 10", "zip": "10034", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Praha 2", "zip": "12808", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Praha 4", "zip": "140 21", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Praha 6", "zip": "169 02", "country": "Czechia", "geoPoint": {"lat": 50.08804, "lon": 14.42076}}, {"city": "Aalborg", "zip": "9000", "country": "Denmark", "geoPoint": {"lat": 57.048, "lon": 9.9187}}, {"city": "Holbaek", "zip": "4300", "country": "Denmark", "geoPoint": {"lat": 55.71354, "lon": 11.7169}}, {"city": "Randers", "zip": "8930", "country": "Denmark", "geoPoint": {"lat": 56.4607, "lon": 10.03639}}, {"city": "BRON Cedex", "zip": "69677", "country": "France", "geoPoint": {"lat": 45.73333, "lon": 4.91667}}, {"city": "Pessac", "zip": "33604", "country": "France", "geoPoint": {"lat": 44.81011, "lon": -0.64129}}, {"city": "Rouen", "zip": "76031", "country": "France", "geoPoint": {"lat": 49.44313, "lon": 1.09932}}, {"city": "Toulouse", "zip": "31403", "country": "France", "geoPoint": {"lat": 43.60426, "lon": 1.44367}}, {"city": "Bad Krozingen", "state": "Baden-W\u00fcrttemberg", "zip": "79189", "country": "Germany", "geoPoint": {"lat": 47.91933, "lon": 7.69045}}, {"city": "M\u00fcnchen", "state": "Bayern", "zip": "80331", "country": "Germany", "geoPoint": {"lat": 48.13743, "lon": 11.57549}}, {"city": "Bad Homburg", "state": "Hessen", "zip": "61348", "country": "Germany", "geoPoint": {"lat": 50.22683, "lon": 8.61816}}, {"city": "Greifswald", "state": "Mecklenburg-Vorpommern", "zip": "17475", "country": "Germany", "geoPoint": {"lat": 54.09311, "lon": 13.38786}}, {"city": "Hannover", "state": "Niedersachsen", "zip": "30625", "country": "Germany", "geoPoint": {"lat": 52.37052, "lon": 9.73322}}, {"city": "K\u00f6ln", "state": "Nordrhein-Westfalen", "zip": "50937", "country": "Germany", "geoPoint": {"lat": 50.93333, "lon": 6.95}}, {"city": "M\u00fcnster", "state": "Nordrhein-Westfalen", "zip": "48149", "country": "Germany", "geoPoint": {"lat": 51.96236, "lon": 7.62571}}, {"city": "Homburg", "state": "Saarland", "zip": "66421", "country": "Germany", "geoPoint": {"lat": 49.32637, "lon": 7.33867}}, {"city": "Erfurt", "state": "Th\u00fcringen", "zip": "99089", "country": "Germany", "geoPoint": {"lat": 50.9787, "lon": 11.03283}}, {"city": "Hamburg", "zip": "20246", "country": "Germany", "geoPoint": {"lat": 53.57532, "lon": 10.01534}}, {"city": "Athens", "zip": "11527", "country": "Greece", "geoPoint": {"lat": 37.97945, "lon": 23.71622}}, {"city": "Chaidari", "zip": "12462", "country": "Greece", "geoPoint": {"lat": 38.01135, "lon": 23.66597}}, {"city": "Nea Ionia / Athens", "zip": "142 33", "country": "Greece"}, {"city": "Budapest", "zip": "1097", "country": "Hungary", "geoPoint": {"lat": 47.49801, "lon": 19.03991}}, {"city": "Kistarcsa", "zip": "H-2143", "country": "Hungary", "geoPoint": {"lat": 47.54757, "lon": 19.26247}}, {"city": "Szekesfehervar", "zip": "8000", "country": "Hungary", "geoPoint": {"lat": 47.18995, "lon": 18.41034}}, {"city": "Afula", "zip": "1834111", "country": "Israel", "geoPoint": {"lat": 32.60907, "lon": 35.2892}}, {"city": "Ashkelon", "zip": "7830604", "country": "Israel", "geoPoint": {"lat": 31.66926, "lon": 34.57149}}, {"city": "Hadera", "zip": "3810101", "country": "Israel", "geoPoint": {"lat": 32.44192, "lon": 34.9039}}, {"city": "Haifa", "zip": "3109601", "country": "Israel", "geoPoint": {"lat": 32.81841, "lon": 34.9885}}, {"city": "Jerusalem", "zip": "9103102", "country": "Israel", "geoPoint": {"lat": 31.76904, "lon": 35.21633}}, {"city": "Petah Tikva", "zip": "4941492", "country": "Israel", "geoPoint": {"lat": 32.08707, "lon": 34.88747}}, {"city": "Rehovot", "zip": "7610001", "country": "Israel", "geoPoint": {"lat": 31.89421, "lon": 34.81199}}, {"city": "Tel Aviv", "zip": "6423906", "country": "Israel", "geoPoint": {"lat": 32.08088, "lon": 34.78057}}, {"city": "Tiberias", "zip": "1528001", "country": "Israel", "geoPoint": {"lat": 32.79221, "lon": 35.53124}}, {"city": "Zrifin", "zip": "7030000", "country": "Israel", "geoPoint": {"lat": 31.95857, "lon": 4.83723}}, {"city": "Bergamo", "state": "Lombardia", "zip": "24127", "country": "Italy", "geoPoint": {"lat": 45.69601, "lon": 9.66721}}, {"city": "Brescia", "state": "Lombardia", "zip": "25123", "country": "Italy", "geoPoint": {"lat": 45.53558, "lon": 10.21472}}, {"city": "Milano", "state": "Lombardia", "zip": "20017", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"city": "Milano", "state": "Lombardia", "zip": "20149", "country": "Italy", "geoPoint": {"lat": 45.46427, "lon": 9.18951}}, {"city": "Pavia", "state": "Lombardia", "zip": "27100", "country": "Italy", "geoPoint": {"lat": 45.19205, "lon": 9.15917}}, {"city": "Ancona", "state": "Marche", "zip": "60126", "country": "Italy", "geoPoint": {"lat": 43.5942, "lon": 13.50337}}, {"city": "Arezzo", "state": "Toscana", "zip": "52040", "country": "Italy", "geoPoint": {"lat": 43.46276, "lon": 11.88068}}, {"city": "Iizuka", "state": "Fukuoka", "zip": "820-8505", "country": "Japan", "geoPoint": {"lat": 33.63654, "lon": 130.68678}}, {"city": "Himeji", "state": "Hyogo", "zip": "670-0981", "country": "Japan", "geoPoint": {"lat": 34.81667, "lon": 134.7}}, {"city": "Higashiibaraki", "state": "Ibaraki", "zip": "311-3193", "country": "Japan"}, {"city": "Kanazawa", "state": "Ishikawa", "zip": "920-8650", "country": "Japan", "geoPoint": {"lat": 36.6, "lon": 136.61667}}, {"city": "Takamatsu", "state": "Kagawa", "zip": "760-0018", "country": "Japan", "geoPoint": {"lat": 34.33333, "lon": 134.05}}, {"city": "Sagamihara", "state": "Kanagawa", "zip": "252-5188", "country": "Japan", "geoPoint": {"lat": 35.54899, "lon": 139.26064}}, {"city": "Yokohama", "state": "Kanagawa", "zip": "236-0051", "country": "Japan", "geoPoint": {"lat": 35.43333, "lon": 139.65}}, {"city": "Yokosuka", "state": "Kanagawa", "zip": "238-8567", "country": "Japan", "geoPoint": {"lat": 35.28361, "lon": 139.66722}}, {"city": "Uji", "state": "Kyoto", "zip": "611-0041", "country": "Japan", "geoPoint": {"lat": 34.89044, "lon": 135.80325}}, {"city": "Naha", "state": "Okinawa", "zip": "902-8511", "country": "Japan", "geoPoint": {"lat": 26.21667, "lon": 127.68333}}, {"city": "Sakai", "state": "Osaka", "zip": "599-8247", "country": "Japan", "geoPoint": {"lat": 34.58333, "lon": 135.46667}}, {"city": "Takatsuki", "state": "Osaka", "zip": "569-1096", "country": "Japan", "geoPoint": {"lat": 34.84833, "lon": 135.61678}}, {"city": "Komatsushima", "state": "Tokushima", "zip": "773-8502", "country": "Japan"}, {"city": "Meguro-ku", "state": "Tokyo", "zip": "152-8902", "country": "Japan", "geoPoint": {"lat": 42.12755, "lon": 143.31736}}, {"city": "Minato-ku", "state": "Tokyo", "zip": "106-0031", "country": "Japan", "geoPoint": {"lat": 34.2152, "lon": 135.1501}}, {"city": "Fukui", "zip": "910-8526", "country": "Japan", "geoPoint": {"lat": 36.06443, "lon": 136.22257}}, {"city": "Hiroshima", "zip": "734-8530", "country": "Japan", "geoPoint": {"lat": 34.4, "lon": 132.45}}, {"city": "Kumamoto", "zip": "862-8505", "country": "Japan", "geoPoint": {"lat": 32.80589, "lon": 130.69182}}, {"city": "Nagasaki", "zip": "850-8555", "country": "Japan", "geoPoint": {"lat": 32.75, "lon": 129.88333}}, {"city": "Osaka", "zip": "558-8558", "country": "Japan", "geoPoint": {"lat": 34.69374, "lon": 135.50218}}, {"city": "Tokushima", "zip": "770-8539", "country": "Japan", "geoPoint": {"lat": 34.06667, "lon": 134.56667}}, {"city": "Toyama", "zip": "930-8550", "country": "Japan", "geoPoint": {"lat": 36.7, "lon": 137.21667}}, {"city": "Seoul", "zip": "138-736", "country": "Korea, Republic of", "geoPoint": {"lat": 37.566, "lon": 126.9784}}, {"city": "Amsterdam", "zip": "1105 AZ", "country": "Netherlands", "geoPoint": {"lat": 52.37403, "lon": 4.88969}}, {"city": "Heerenveen", "zip": "8441 PW", "country": "Netherlands", "geoPoint": {"lat": 52.95929, "lon": 5.91854}}, {"city": "Leeuwarden", "zip": "8934 AD", "country": "Netherlands", "geoPoint": {"lat": 53.20139, "lon": 5.80859}}, {"city": "Sneek", "zip": "8601 ZR", "country": "Netherlands", "geoPoint": {"lat": 53.03297, "lon": 5.6589}}, {"city": "Bialystok", "zip": "15-276", "country": "Poland", "geoPoint": {"lat": 53.13333, "lon": 23.16433}}, {"city": "Krakow", "zip": "31-121", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"city": "Krakow", "zip": "31-202", "country": "Poland", "geoPoint": {"lat": 50.06143, "lon": 19.93658}}, {"city": "Lodz", "zip": "92-213", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"city": "Lodz", "zip": "93-513", "country": "Poland", "geoPoint": {"lat": 51.75, "lon": 19.46667}}, {"city": "Olsztyn", "zip": "10-010", "country": "Poland", "geoPoint": {"lat": 53.77995, "lon": 20.49416}}, {"city": "Poznan", "zip": "61-848", "country": "Poland", "geoPoint": {"lat": 52.40692, "lon": 16.92993}}, {"city": "Szczecin", "zip": "70-965", "country": "Poland", "geoPoint": {"lat": 53.42894, "lon": 14.55302}}, {"city": "Almada", "zip": "2801-951", "country": "Portugal", "geoPoint": {"lat": 38.67902, "lon": -9.1569}}, {"city": "Lisboa", "zip": "1449-005", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"city": "Lisboa", "zip": "1500-650", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"city": "Lisboa", "zip": "1649-035", "country": "Portugal", "geoPoint": {"lat": 38.71667, "lon": -9.13333}}, {"city": "Singapore", "zip": "119228", "country": "Singapore", "geoPoint": {"lat": 1.28967, "lon": 103.85007}}, {"city": "Singapore", "zip": "169609", "country": "Singapore", "geoPoint": {"lat": 1.28967, "lon": 103.85007}}, {"city": "Singapore", "zip": "308433", "country": "Singapore", "geoPoint": {"lat": 1.28967, "lon": 103.85007}}, {"city": "Singapore", "zip": "768828", "country": "Singapore", "geoPoint": {"lat": 1.28967, "lon": 103.85007}}, {"city": "Santander", "state": "Cantabria", "zip": "39008", "country": "Spain", "geoPoint": {"lat": 43.46472, "lon": -3.80444}}, {"city": "Majadahonda", "state": "Madrid", "zip": "28222", "country": "Spain", "geoPoint": {"lat": 40.47353, "lon": -3.87182}}, {"city": "El Palmar", "state": "Murcia", "zip": "30120", "country": "Spain", "geoPoint": {"lat": 37.93939, "lon": -1.16095}}, {"city": "Barcelona", "zip": "08003", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Barcelona", "zip": "08023", "country": "Spain", "geoPoint": {"lat": 41.38879, "lon": 2.15899}}, {"city": "Valencia", "zip": "46010", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"city": "Valencia", "zip": "46026", "country": "Spain", "geoPoint": {"lat": 39.46975, "lon": -0.37739}}, {"city": "Helsingborg", "zip": "251 87", "country": "Sweden", "geoPoint": {"lat": 56.04673, "lon": 12.69437}}, {"city": "Karlstad", "zip": "652 30", "country": "Sweden", "geoPoint": {"lat": 59.3793, "lon": 13.50357}}, {"city": "Link\u00f6ping", "zip": "581 85", "country": "Sweden", "geoPoint": {"lat": 58.41086, "lon": 15.62157}}, {"city": "Stockholm", "zip": "118 83", "country": "Sweden", "geoPoint": {"lat": 59.33258, "lon": 18.0649}}, {"city": "\u00d6rebro", "zip": "701 85", "country": "Sweden", "geoPoint": {"lat": 59.27412, "lon": 15.2066}}, {"city": "Lugano", "state": "Ticino", "zip": "6900", "country": "Switzerland", "geoPoint": {"lat": 46.01008, "lon": 8.96004}}, {"city": "Gen\u00e8ve", "zip": "1205", "country": "Switzerland", "geoPoint": {"lat": 46.20222, "lon": 6.14569}}, {"city": "Kaohsiung", "zip": "813", "country": "Taiwan", "geoPoint": {"lat": 22.61626, "lon": 120.31333}}, {"city": "New Taipei City", "zip": "220", "country": "Taiwan", "geoPoint": {"lat": 25.01111, "lon": 121.44583}}, {"city": "Taipei", "zip": "10016", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"city": "Taipei", "zip": "11217", "country": "Taiwan", "geoPoint": {"lat": 25.04776, "lon": 121.53185}}, {"city": "Taoyuan", "zip": "333423", "country": "Taiwan", "geoPoint": {"lat": 24.95233, "lon": 121.20193}}, {"city": "Chesterfield", "state": "Derbyshire", "zip": "S44 5DX", "country": "United Kingdom", "geoPoint": {"lat": 53.25, "lon": -1.41667}}, {"city": "Stevenage", "state": "Hertfordshire", "zip": "SG1 4AB", "country": "United Kingdom", "geoPoint": {"lat": 51.90224, "lon": -0.20256}}]}, "referencesModule": {"references": [{"pmid": "25056511", "type": "BACKGROUND", "citation": "Pieske B, Butler J, Filippatos G, Lam C, Maggioni AP, Ponikowski P, Shah S, Solomon S, Kraigher-Krainer E, Samano ET, Scalise AV, Muller K, Roessig L, Gheorghiade M; SOCRATES Investigators and Coordinators. Rationale and design of the SOluble guanylate Cyclase stimulatoR in heArT failurE Studies (SOCRATES). Eur J Heart Fail. 2014 Sep;16(9):1026-38. doi: 10.1002/ejhf.135. Epub 2014 Jul 24."}], "seeAlsoLinks": [{"label": "Click here to find results for studies related to Bayer Healthcare products.", "url": "https://clinicaltrials.bayer.com/"}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "Overall, 632 subjects were enrolled, of them 477 were randomized and 475 were treated. Among the 477 subjects who were randomized, 404 subjects completed both treatment and follow-up \\[FU\\] periods. All arms in FU period were mutually exclusive, this question below is ticked No because of database validation rule constraints.", "recruitmentDetails": "The study was conducted at 158 centers in 25 countries between 06 November 2013 (first subject first visit) and 16 September 2015 (last subject last visit).", "groups": [{"id": "FG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "FG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "FG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "FG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "FG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}], "periods": [{"title": "Treatment Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "93"}, {"groupId": "FG001", "numSubjects": "96"}, {"groupId": "FG002", "numSubjects": "96"}, {"groupId": "FG003", "numSubjects": "96"}, {"groupId": "FG004", "numSubjects": "96"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "80"}, {"groupId": "FG001", "numSubjects": "82"}, {"groupId": "FG002", "numSubjects": "83"}, {"groupId": "FG003", "numSubjects": "80"}, {"groupId": "FG004", "numSubjects": "86"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "13"}, {"groupId": "FG001", "numSubjects": "14"}, {"groupId": "FG002", "numSubjects": "13"}, {"groupId": "FG003", "numSubjects": "16"}, {"groupId": "FG004", "numSubjects": "10"}]}], "dropWithdraws": [{"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "2"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Protocol-driven decision point", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "3"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Logistical difficulties", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "9"}, {"groupId": "FG001", "numSubjects": "6"}, {"groupId": "FG002", "numSubjects": "4"}, {"groupId": "FG003", "numSubjects": "5"}, {"groupId": "FG004", "numSubjects": "4"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "3"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "3"}, {"groupId": "FG001", "numSubjects": "4"}, {"groupId": "FG002", "numSubjects": "8"}, {"groupId": "FG003", "numSubjects": "6"}, {"groupId": "FG004", "numSubjects": "5"}]}]}, {"title": "Follow-up Period", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "89"}, {"groupId": "FG001", "numSubjects": "95"}, {"groupId": "FG002", "numSubjects": "95"}, {"groupId": "FG003", "numSubjects": "88"}, {"groupId": "FG004", "numSubjects": "94"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "87"}, {"groupId": "FG001", "numSubjects": "86"}, {"groupId": "FG002", "numSubjects": "90"}, {"groupId": "FG003", "numSubjects": "80"}, {"groupId": "FG004", "numSubjects": "89"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "2"}, {"groupId": "FG001", "numSubjects": "9"}, {"groupId": "FG002", "numSubjects": "5"}, {"groupId": "FG003", "numSubjects": "8"}, {"groupId": "FG004", "numSubjects": "5"}]}], "dropWithdraws": [{"type": "Protocol Violation", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Logistical difficulties", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "2"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "0"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "5"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "2"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "0"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "0"}]}, {"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "1"}, {"groupId": "FG001", "numSubjects": "0"}, {"groupId": "FG002", "numSubjects": "1"}, {"groupId": "FG003", "numSubjects": "4"}, {"groupId": "FG004", "numSubjects": "1"}]}, {"type": "Adverse Event", "reasons": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "1"}, {"groupId": "FG002", "numSubjects": "2"}, {"groupId": "FG003", "numSubjects": "1"}, {"groupId": "FG004", "numSubjects": "1"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "BG001", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "BG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "BG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "BG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}, {"id": "BG005", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "96"}, {"groupId": "BG001", "value": "93"}, {"groupId": "BG002", "value": "96"}, {"groupId": "BG003", "value": "96"}, {"groupId": "BG004", "value": "96"}, {"groupId": "BG005", "value": "477"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "73.8", "spread": "10"}, {"groupId": "BG001", "value": "73.7", "spread": "9.1"}, {"groupId": "BG002", "value": "72", "spread": "10.7"}, {"groupId": "BG003", "value": "73.9", "spread": "7.9"}, {"groupId": "BG004", "value": "72.5", "spread": "10.2"}, {"groupId": "BG005", "value": "73.2", "spread": "9.6"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "51"}, {"groupId": "BG001", "value": "46"}, {"groupId": "BG002", "value": "43"}, {"groupId": "BG003", "value": "43"}, {"groupId": "BG004", "value": "44"}, {"groupId": "BG005", "value": "227"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "45"}, {"groupId": "BG001", "value": "47"}, {"groupId": "BG002", "value": "53"}, {"groupId": "BG003", "value": "53"}, {"groupId": "BG004", "value": "52"}, {"groupId": "BG005", "value": "250"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Change From Baseline to Week 12 in Log-transformed N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)", "description": "NTproBNP is a circulating plasma biomarker of cardiovascular function and prognosis in heart failure (HF).", "populationDescription": "Per Protocol Set (PPS) NT-pro BNP: included all subjects randomized to treatment who had a valid measurement of NT-pro BNP at baseline and at Week 12 (Visit 5) and showed no major protocol deviations.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "log-transformed picograms per milliliter", "timeFrame": "Baseline, Week 12 (end of treatment [EOT])", "groups": [{"id": "OG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "OG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "73"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "78"}, {"groupId": "OG003", "value": "57"}, {"groupId": "OG004", "value": "60"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-0.098", "spread": "0.778"}, {"groupId": "OG001", "value": "-0.047", "spread": "0.788"}, {"groupId": "OG002", "value": "0.071", "spread": "0.818"}, {"groupId": "OG003", "value": "0.057", "spread": "0.819"}, {"groupId": "OG004", "value": "-0.023", "spread": "0.705"}]}]}], "analyses": [{"groupIds": ["OG000"], "groupDescription": "For the primary analysis, the three highest active treatment groups BAY1021189 (2.5mg, 2.5 to 5mg, 2.5 to 10mg) were pooled and compared to the assigned placebo treatment group with a one-sided two-sample t-test. The Hochberg procedure was used to test the two primary end points at study-wise significance level of 5%. Results are reported including 90% confidence intervals (CI) for the difference of means. The difference between the comparison groups is difference of means on the log scale.", "nonInferiorityType": "OTHER", "pValue": "= 0.8991", "statisticalMethod": "t-test, 1 sided", "paramType": "Log-Scale mean difference", "paramValue": "0.137", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.04", "ciUpperLimit": "0.31"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.7194", "statisticalMethod": "t-test, 1 sided", "paramType": "Log-Scale mean difference", "paramValue": "0.076", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.18", "ciUpperLimit": "0.33"}, {"groupIds": ["OG000", "OG003"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.8653", "statisticalMethod": "t-test, 1 sided", "paramType": "Log-Scale mean difference", "paramValue": "0.156", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.12", "ciUpperLimit": "0.43"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.9041", "statisticalMethod": "t-test, 1 sided", "paramType": "Log-Scale mean difference", "paramValue": "0.171", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.09", "ciUpperLimit": "0.43"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.6572", "statisticalMethod": "t-test, 1 sided", "paramType": "Log-Scale mean difference", "paramValue": "0.052", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-0.2", "ciUpperLimit": "0.3"}]}, {"type": "PRIMARY", "title": "Change From Baseline to Week 12 in Left Atrial Volume (LAV)", "description": "Left atrial volume was measured by echocardiography.", "populationDescription": "PPS Left Atrial Volume (LAV) included all subjects randomized to treatment who had a valid measurement of LAV at baseline and at Week 12 (Visit 5) and showed no major protocol deviations.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "milliliter", "timeFrame": "Baseline, Week 12 (EOT)", "groups": [{"id": "OG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "OG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "67"}, {"groupId": "OG001", "value": "77"}, {"groupId": "OG002", "value": "78"}, {"groupId": "OG003", "value": "57"}, {"groupId": "OG004", "value": "59"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "-3.361", "spread": "12.654", "lowerLimit": "12.654"}, {"groupId": "OG001", "value": "-2.163", "spread": "7.895", "lowerLimit": "7.895"}, {"groupId": "OG002", "value": "-2.142", "spread": "11.931", "lowerLimit": "11.931"}, {"groupId": "OG003", "value": "-1.252", "spread": "16.139", "lowerLimit": "16.139"}, {"groupId": "OG004", "value": "-1.654", "spread": "10.245", "lowerLimit": "10.245"}]}]}], "analyses": [{"groupIds": ["OG000"], "groupDescription": "For the primary analysis, the three highest active treatment groups (BAY1021189 2.5mg, BAY1021189 2.5 to 5mg, BAY1021189 2.5 to 10mg) were pooled and compared to the assigned placebo treatment group with a one-sided two-sample t-test. The Hochberg procedure was used to test the two primary end points at study-wise significance level of 5%. Results are reported including 90% confidence intervals (CI) for the difference of means.", "nonInferiorityType": "OTHER", "pValue": "= 0.8156", "statisticalMethod": "t-test, 1 sided", "paramType": "Mean Difference (Net)", "paramValue": "1.629", "ciPctValue": "90", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-1.36", "ciUpperLimit": "4.62"}, {"groupIds": ["OG000", "OG004"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.7945", "statisticalMethod": "t-test, 1 sided", "paramType": "Mean Difference (Net)", "paramValue": "1.707", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-2.39", "ciUpperLimit": "5.8"}, {"groupIds": ["OG000", "OG003"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.7917", "statisticalMethod": "t-test, 1 sided", "paramType": "Mean Difference (Net)", "paramValue": "2.109", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-3.01", "ciUpperLimit": "7.23"}, {"groupIds": ["OG000", "OG002"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.7241", "statisticalMethod": "t-test, 1 sided", "paramType": "Mean Difference (Net)", "paramValue": "1.219", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-2.82", "ciUpperLimit": "5.26"}, {"groupIds": ["OG000", "OG001"], "groupDescription": "Pairwise comparisons to placebo were performed in a hierarchical manner (from BAY1021189 from 2.5 to 10mg dose arm to BAY1021189 1.25mg dose arm). In accordance with the specification in the protocol these secondary analyses are considered exploratory only, since the primary analyses were not significant.", "nonInferiorityType": "OTHER", "pValue": "= 0.7546", "statisticalMethod": "t-test, 1 sided", "paramType": "Mean Difference (Net)", "paramValue": "1.198", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "-2.23", "ciUpperLimit": "4.63"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change From Baseline to Week 12 Systolic Blood Pressure (SBP) and Diastolic Blood Pressure (DBP)", "description": "Blood pressure was measured after at least 10 minutes resting in a sitting position (3 measurements taken approximately 2 minutes apart).The changes in blood pressure were recorded and the mean of the three measurements was analyzed.", "populationDescription": "Safety Analysis Set (SAF) with evaluable subjects for this endpoint.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "millimeter of mercury", "timeFrame": "Baseline, Week 12 (EOT)", "groups": [{"id": "OG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "OG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}, {"groupId": "OG001", "value": "82"}, {"groupId": "OG002", "value": "83"}, {"groupId": "OG003", "value": "61"}, {"groupId": "OG004", "value": "61"}]}], "classes": [{"title": "Change in SBP", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.458", "spread": "18.865"}, {"groupId": "OG001", "value": "0.703", "spread": "16.993"}, {"groupId": "OG002", "value": "-1.819", "spread": "19.438"}, {"groupId": "OG003", "value": "-1.486", "spread": "17.179"}, {"groupId": "OG004", "value": "-0.913", "spread": "15.498"}]}]}, {"title": "Change in DBP", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.887", "spread": "11.435"}, {"groupId": "OG001", "value": "0.911", "spread": "10.037"}, {"groupId": "OG002", "value": "-2.173", "spread": "11.249"}, {"groupId": "OG003", "value": "-1.142", "spread": "11.4"}, {"groupId": "OG004", "value": "-0.629", "spread": "10.271"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Change From Baseline to Week 12 in Heart Rate", "description": "Heart rate was measured after 10 minutes resting in a sitting position (3 measurements taken approximatly 2 minutes apart). The changes in heart rate were recorded and the mean of the three measurements was analyzed.", "populationDescription": "Safety Analysis Set (SAF) with evaluable subjects for this endpoint.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Standard Deviation", "unitOfMeasure": "beats per minute", "timeFrame": "Baseline, Week 12 (EOT)", "groups": [{"id": "OG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "OG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "80"}, {"groupId": "OG001", "value": "82"}, {"groupId": "OG002", "value": "83"}, {"groupId": "OG003", "value": "61"}, {"groupId": "OG004", "value": "61"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "3.287", "spread": "13.582", "lowerLimit": "13.582"}, {"groupId": "OG001", "value": "1.776", "spread": "11.42", "lowerLimit": "11.42"}, {"groupId": "OG002", "value": "-0.373", "spread": "9.845", "lowerLimit": "9.845"}, {"groupId": "OG003", "value": "1.055", "spread": "13.331", "lowerLimit": "13.331"}, {"groupId": "OG004", "value": "-2.623", "spread": "9.639", "lowerLimit": "9.639"}]}]}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Subjects With Clinical Events (Heart Failure Hospitalization and Cardio-vascular [CV] Mortality)", "description": "Clinical events (heart failure and mortality) were analyzed as CV death, and HF hospitalization at specified time points.", "populationDescription": "Full Analysis Set (FAS) included all subjects who were randomized to treatment.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "Baseline up to Week 16 including 12 week treatment period and 4 week follow-up period", "groups": [{"id": "OG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28."}, {"id": "OG003", "title": "BAY1021189 2.5 mg to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg after 14 or 28 days. Sham titration included on Day 28."}, {"id": "OG004", "title": "BAY1021189 2.5 mg to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "93"}, {"groupId": "OG001", "value": "96"}, {"groupId": "OG002", "value": "96"}, {"groupId": "OG003", "value": "96"}, {"groupId": "OG004", "value": "96"}]}], "classes": [{"title": "HF hospitalizations", "categories": [{"measurements": [{"groupId": "OG000", "value": "8"}, {"groupId": "OG001", "value": "6"}, {"groupId": "OG002", "value": "11"}, {"groupId": "OG003", "value": "8"}, {"groupId": "OG004", "value": "5"}]}]}, {"title": "CV Mortality", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "0"}, {"groupId": "OG002", "value": "0"}, {"groupId": "OG003", "value": "5"}, {"groupId": "OG004", "value": "1"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "5", "timeFrame": "Treatment-emergent AEs were collected after first application of study medication up to 5 calendar days after end of treatment with study medication", "eventGroups": [{"id": "EG000", "title": "Placebo", "description": "Subjects received placebo matched to vericiguat (BAY1021189) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28.", "deathsNumAffected": 1, "deathsNumAtRisk": 93, "seriousNumAffected": 20, "seriousNumAtRisk": 93, "otherNumAffected": 21, "otherNumAtRisk": 93}, {"id": "EG001", "title": "BAY1021189 1.25 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 1.25 milligram (mg) orally once daily for 12 weeks. Sham titrations included on Days 14 and 28.", "deathsNumAffected": 0, "deathsNumAtRisk": 96, "seriousNumAffected": 20, "seriousNumAtRisk": 96, "otherNumAffected": 33, "otherNumAtRisk": 96}, {"id": "EG002", "title": "BAY1021189 2.5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) 2.5 mg orally once daily for 12 weeks. Sham titrations included on Days 14 and 28.", "deathsNumAffected": 1, "deathsNumAtRisk": 95, "seriousNumAffected": 24, "seriousNumAtRisk": 95, "otherNumAffected": 40, "otherNumAtRisk": 95}, {"id": "EG003", "title": "BAY1021189 From 2.5 to 5 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 or 28 days. Sham titration included on Day 28.", "deathsNumAffected": 7, "deathsNumAtRisk": 95, "seriousNumAffected": 18, "seriousNumAtRisk": 95, "otherNumAffected": 38, "otherNumAtRisk": 95}, {"id": "EG004", "title": "BAY1021189 From 2.5 to 10 mg", "description": "Subjects received vericiguat (Verquvo, BAY1021189) for 12 weeks, starting on 2.5 mg once daily with potential up-titration to 5 mg once daily after 14 days, and up-titration to 10 mg once daily after 28 days.", "deathsNumAffected": 2, "deathsNumAtRisk": 96, "seriousNumAffected": 21, "seriousNumAtRisk": 96, "otherNumAffected": 33, "otherNumAtRisk": 96}], "seriousEvents": [{"term": "Anaemia", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Anaemia of chronic disease", "organSystem": "Blood and lymphatic system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Angina unstable", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Atrial fibrillation", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 3, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Cardiac arrest", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 6, "numAffected": 6, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 12, "numAffected": 7, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 8, "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}]}, {"term": "Cardiac failure acute", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Cardiac failure chronic", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 5, "numAffected": 4, "numAtRisk": 96}]}, {"term": "Cardiac failure congestive", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 3, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Cardiogenic shock", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Myocardial infarction", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Right ventricular failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Tachyarrhythmia", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Acute coronary syndrome", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Vertigo", "organSystem": "Ear and labyrinth disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Vitreous haemorrhage", "organSystem": "Eye disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Diarrhoea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Gastrointestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Large intestine polyp", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Intestinal haemorrhage", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Chest pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Pain", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Pyrexia", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Sudden death", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Cholelithiasis", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Jaundice cholestatic", "organSystem": "Hepatobiliary disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Carbuncle", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Diabetic gangrene", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Erysipelas", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Gangrene", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Gastroenteritis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Hepatitis C", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Osteomyelitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Pneumonia", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 3, "numAffected": 3, "numAtRisk": 96}]}, {"term": "Respiratory syncytial virus bronchiolitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Urinary tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Urosepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Urinary tract infection bacterial", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Enterococcal sepsis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Chlamydial infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Respiratory tract infection", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Femoral neck fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Radius fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Ulna fracture", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Vascular pseudoaneurysm", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Contusion", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Post procedural haematoma", "organSystem": "Injury, poisoning and procedural complications", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Coagulation time prolonged", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Intraocular pressure increased", "organSystem": "Investigations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Diabetes mellitus", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Failure to thrive", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Hypoglycaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Osteochondrosis", "organSystem": "Musculoskeletal and connective tissue disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Non-Hodgkin's lymphoma", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Gastrointestinal stromal tumour", "organSystem": "Neoplasms benign, malignant and unspecified (incl cysts and polyps)", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Carotid artery stenosis", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Cerebral haemorrhage", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Presyncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Syncope", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Cervicogenic headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Renal impairment", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 4, "numAffected": 4, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 3, "numAffected": 3, "numAtRisk": 96}]}, {"term": "Acute pulmonary oedema", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Chronic obstructive pulmonary disease", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Epistaxis", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Pleural effusion", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Pulmonary hypertension", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Respiratory failure", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Diabetic foot", "organSystem": "Skin and subcutaneous tissue disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Eyelid operation", "organSystem": "Surgical and medical procedures", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Circulatory collapse", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Orthostatic hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}], "otherEvents": [{"term": "Cardiac failure", "organSystem": "Cardiac disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 5, "numAffected": 5, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 4, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 3, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}]}, {"term": "Abdominal pain upper", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 5, "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Nausea", "organSystem": "Gastrointestinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 5, "numAffected": 4, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 5, "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 5, "numAffected": 4, "numAtRisk": 96}]}, {"term": "Fatigue", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 3, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 6, "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 4, "numAffected": 4, "numAtRisk": 96}]}, {"term": "Oedema peripheral", "organSystem": "General disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 4, "numAffected": 3, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 3, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 7, "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Bronchitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 4, "numAffected": 4, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 6, "numAffected": 6, "numAtRisk": 96}]}, {"term": "Nasopharyngitis", "organSystem": "Infections and infestations", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 8, "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 5, "numAffected": 5, "numAtRisk": 96}]}, {"term": "Hyperkalaemia", "organSystem": "Metabolism and nutrition disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 0, "numAffected": 0, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 6, "numAffected": 6, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 2, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 3, "numAffected": 3, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 3, "numAffected": 3, "numAtRisk": 96}]}, {"term": "Dizziness", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 4, "numAffected": 2, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 11, "numAffected": 10, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 6, "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 7, "numAffected": 7, "numAtRisk": 96}]}, {"term": "Headache", "organSystem": "Nervous system disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 6, "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 4, "numAffected": 4, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 4, "numAffected": 4, "numAtRisk": 96}]}, {"term": "Renal failure", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 2, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 1, "numAffected": 1, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 0, "numAffected": 0, "numAtRisk": 96}]}, {"term": "Acute kidney injury", "organSystem": "Renal and urinary disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 0, "numAffected": 0, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 5, "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 1, "numAffected": 1, "numAtRisk": 96}]}, {"term": "Cough", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 5, "numAffected": 5, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 6, "numAffected": 6, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 2, "numAffected": 2, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}]}, {"term": "Dyspnoea", "organSystem": "Respiratory, thoracic and mediastinal disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 3, "numAffected": 3, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 7, "numAffected": 6, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 10, "numAffected": 9, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 6, "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 3, "numAffected": 3, "numAtRisk": 96}]}, {"term": "Hypotension", "organSystem": "Vascular disorders", "sourceVocabulary": "MedDRA 18.0", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 93}, {"groupId": "EG001", "numEvents": 4, "numAffected": 4, "numAtRisk": 96}, {"groupId": "EG002", "numEvents": 6, "numAffected": 4, "numAtRisk": 95}, {"groupId": "EG003", "numEvents": 5, "numAffected": 5, "numAtRisk": 95}, {"groupId": "EG004", "numEvents": 2, "numAffected": 2, "numAtRisk": 96}]}]}, "moreInfoModule": {"limitationsAndCaveats": {"description": "End points, \"Health-related quality of life, Composite Congestion Score, NYHA function class, echo parameters other than LAV, biomarker and background HF therapies\" were exploratory. \"Incidence of atrial fibrillation\" is reported in AE section."}, "certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Therapeutic Area Head", "organization": "Bayer AG", "email": "clinical-trials-contact@bayer.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24", "removedCountries": ["China", "Czech Republic"]}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}, {"id": "T1303", "name": "Chronic Graft Versus Host Disease", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}, {"abbrev": "Rare", "name": "Rare Diseases"}]}}, "hasResults": true}